---
document_datetime: 2024-04-11 14:32:40
document_pages: 15
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/myclausen-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: myclausen-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 9.3121833
conversion_datetime: 2025-12-20 09:26:37.525853
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Myclausen

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                 |
|----------------------|----------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10550 /202305  | Periodic Safety Update EU Single assessment - mycophenolate mofetil, mycophenolic acid | 25/01/2024                          | 27/03/2024                                  | SmPC                             | Please refer to CellCept, Myclausen, Mycophenolate mofetil teva, Myfenax EMEA/H/C/PSUSA/00010550/202305 EPAR: Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation |
| IB/0057              | B.II.b.3.a - Change in the manufacturing process of                                    | 06/07/2023                          | n/a                                         |                                  |                                                                                                                                                                                                                         |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |             |                                                                                                                                                                                                                                                                                                                                                           |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0056   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                                                                                                                                 | 29/03/2023 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                           |
| IB/0055/G | This was an application for a group of variations. B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process | 22/12/2022 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                           |
| IB/0054/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                                                                                                                                                                                                                      | 01/08/2022 | 30/08/2023 | SmPC and PL | Section 5.1 of the SmPC has been updated based on a literature review on mycophenolate mechanism of action. Section 5.2 of the SmPC has been updated to add new information to the Distribution and Elimination subsections. Sections 4.5 and 5.2 of the SmPC have been updated to amend the existing information on patients taking oral contraceptives. |

<div style=\"page-break-after: always\"></div>

|                     | the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by   |            |            | Section 2 of the Package Leaflet has been updated to align the wording of the text with the SmPC section 4.4.                              |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10550 /202105 | Periodic Safety Update EU Single assessment - mycophenolate mofetil, mycophenolic acid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 16/12/2021 | 16/02/2022 | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10550/202105. |
| IA/0053             | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 24/08/2021 | n/a        |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|                     | relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |             |                                                                                                                                            |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0051             | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 16/07/2021 | 16/02/2022 | SmPC and PL |                                                                                                                                            |
| PSUSA/10550 /202005 | Periodic Safety Update EU Single assessment - mycophenolate mofetil, mycophenolic acid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 10/12/2020 | 18/02/2021 | SmPC        | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10550/202005. |
| IA/0050/G           | This was an application for a group of variations. B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch | 23/12/2020 | n/a        |             |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|                     | control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                    |            |     |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IA/0048             | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                               | 29/01/2020 | n/a |                                   |
| PSUSA/10550 /201905 | Periodic Safety Update EU Single assessment - mycophenolate mofetil, mycophenolic acid                                                                                                                                                                                                                                                                                                                                         | 28/11/2019 | n/a | PRAC Recommendation - maintenance |
| IB/0046/G           | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place | 17/04/2019 | n/a |                                   |
| IA/0045/G           | This was an application for a group of variations. B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting               | 19/03/2019 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. TSE New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.2 - Submission deletion of Ph. Eur. TSE New certificate for a material/reagent/intermediate/or new or an already approved B.III.1.b.4 - Submission deletion of Ph. Eur. TSE Deletion of certificates exist per material) B.III.1.b.4 - Submission deletion of Ph. Eur. TSE Deletion of certificates exist per material) B.III.1.b.4 - Submission deletion of Ph. Eur. TSE Deletion of certificates exist per material) B.III.1.b.4 - Submission deletion of Ph. Eur. TSE Deletion of certificates exist per material) B.III.1.b.4 - Submission deletion of Ph. Eur. TSE Deletion of certificates   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                     | B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates exist per material)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |            |             |                                                                                                                                            |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10550 /201805 | Periodic Safety Update EU Single assessment - mycophenolate mofetil, mycophenolic acid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 29/11/2018 | n/a        |             | PRAC Recommendation - maintenance                                                                                                          |
| IA/0044             | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 20/11/2018 | n/a        |             |                                                                                                                                            |
| PSUSA/10550 /201705 | Periodic Safety Update EU Single assessment - mycophenolate mofetil, mycophenolic acid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 14/12/2017 | 05/03/2018 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10550/201705. |
| IA/0042/G           | This was an application for a group of variations. B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient | 26/10/2017 | n/a        |             |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|           | an approved test procedure B.II.c.2.b - Change in test procedure for an excipient - Deletion of a test procedure if an alternative test procedure is already authorised B.II.c.2.b - Change in test procedure for an excipient - Deletion of a test procedure if an alternative test procedure is already authorised   |            |            |                 | - Minor changes to   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|----------------------|
| IA/0040/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer           | 14/06/2017 | n/a        |                 |                      |
| IA/0039   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                          | 11/05/2017 | 05/03/2018 | Annex II and PL |                      |
| N/0038    | Update of the package leaflet with revised contact details of the local representative for Czech Republic. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                            | 13/10/2016 | 05/03/2018 | PL              |                      |
| IA/0037   | B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer                                                                                                                                                           | 22/07/2016 | n/a        |                 |                      |

<div style=\"page-break-after: always\"></div>

| IAIN/0036   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                           | 03/06/2016   | n/a        |                        |               |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|---------------|
| IAIN/0035   | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                       | 18/03/2016   | 12/08/2016 | Annex II and PL        |               |
| IB/0033     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 08/02/2016   | 12/08/2016 | SmPC, Annex II and PL  |               |
| IAIN/0034   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the                                                                                                            | 22/12/2015   | n/a        |                        | PSMF location |
| IAIN/0032   | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                   | 14/12/2015   | 12/08/2016 | SmPC, Labelling and PL |               |
| IB/0031/G   | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO         | 18/08/2015   | 12/08/2016 | SmPC, Annex II and PL  |               |

<div style=\"page-break-after: always\"></div>

|           | new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by   |            |            |                           |                                                                                                                      |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|---------------------------|----------------------------------------------------------------------------------------------------------------------|
| IAIN/0030 | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 12/08/2015 | 12/08/2016 | SmPC, Labelling and PL    |                                                                                                                      |
| IA/0029   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 16/07/2015 | n/a        |                           |                                                                                                                      |
| R/0023    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 26/03/2015 | 27/05/2015 | SmPC, Annex II, Labelling | Based on the review of data on quality, safety and efficacy, including all variations introduced since the marketing |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            | and PL      | authorisation was granted, the CHMP considered that the benefit-risk balance of Myclausen in the approved indications remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity.   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0028   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                | 29/01/2015 | 27/05/2015 | SmPC and PL |                                                                                                                                                                                                                                          |
| IA/0027   | B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                | 23/12/2014 | n/a        |             |                                                                                                                                                                                                                                          |
| IA/0025/G | This was an application for a group of variations. B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer | 23/12/2014 | n/a        |             |                                                                                                                                                                                                                                          |
| IA/0026   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the                                                                                                                                                                                                                                                                                                                                         | 22/12/2014 | n/a        |             |                                                                                                                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

|           | Ph. Eur. Monograph - Updated certificate an already approved manufacturer                                                                                                                                                                                                                                                                                                                                            |            |            |                                  | relevant from   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------|
| IA/0024   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                          | 22/12/2014 | n/a        |                                  |                 |
| IA/0022/G | This was an application for a group of variations. B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of | 24/10/2014 | 27/05/2015 | Annex II and PL                  | manufacturing   |
| N/0021    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                     | 24/04/2014 | 27/10/2014 | PL                               |                 |
| IB/0020   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                         | 30/10/2013 | 27/10/2014 | SmPC, Annex II, Labelling and PL |                 |

<div style=\"page-break-after: always\"></div>

| IB/0019     | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                        | 21/10/2013   | 27/10/2014   | SmPC        |                                                                                                                                                                                                                                                                                                                                                                                                         |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0018   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                               | 11/09/2013   | n/a          |             |                                                                                                                                                                                                                                                                                                                                                                                                         |
| IB/0017     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH   | 13/09/2012   | 29/10/2012   | SmPC and PL | Update of Section 4.5 of the SmPC to include information regarding the interaction with proton pump inhibitors following the outcome of PSUR 18 assessment (covering period: 01.05.08-30.04.11) of the Reference Product. The Package Leaflet has been updated accordingly. The MAH also took the opportunity to introduce minor linguistic amendments in the Danish, Finish, Norwegian and Swedish PI. |
| IAIN/0016/G | This was an application for a group of variations. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation | 10/09/2012   | n/a          |             |                                                                                                                                                                                                                                                                                                                                                                                                         |
| IB/0015     | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                        | 16/12/2011   | 28/06/2012   | SmPC        |                                                                                                                                                                                                                                                                                                                                                                                                         |
| N/0014      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                 | 25/10/2011   | n/a          | PL          |                                                                                                                                                                                                                                                                                                                                                                                                         |

<div style=\"page-break-after: always\"></div>

| X/0003   | To register a new pharmaceutical form and strength 250 mg hard capsules Annex I_2.(d) Change or addition of a new                                                   | 21/07/2011   | 16/09/2011   | SmPC, Labelling and PL   | pharmaceutical form   |
|----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|-----------------------|
| N/0013   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                    | 09/06/2011   | n/a          | PL                       |                       |
| N/0012   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                    | 05/04/2011   | n/a          | PL                       |                       |
| IA/0010  | B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement or addition of a site where batch control/testing takes place | 15/03/2011   | n/a          |                          |                       |
| IA/0009  | B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement or addition of a site where batch control/testing takes place | 15/03/2011   | n/a          |                          |                       |
| IA/0006  | B.II.b.2.b.1 - Change to batch release arrangements and quality control testing of the FP - Not including batch control/testing                                     | 15/03/2011   | n/a          | Annex II and PL          |                       |
| IA/0005  | B.II.b.2.b.1 - Change to batch release arrangements and quality control testing of the FP - Not including batch control/testing                                     | 15/03/2011   | n/a          | Annex II and PL          |                       |
| IA/0004  | B.III.1.a.3 - Submission of a new or updated Ph. Eur.                                                                                                               | 15/03/2011   | n/a          |                          |                       |

<div style=\"page-break-after: always\"></div>

|         | Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from a new manufacturer (replacement or addition)                                                                                                                          |            |     |    |                                                                                                                                                                                                         |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0011 | B.III.1.a.2 - Submission of a new or updated Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                            | 11/03/2011 | n/a |    |                                                                                                                                                                                                         |
| IA/0008 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                         | 11/03/2011 | n/a |    |                                                                                                                                                                                                         |
| IA/0007 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                         | 11/03/2011 | n/a |    |                                                                                                                                                                                                         |
| IB/0001 | C.I.3.a - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under A 45/46, or amendments to reflect a Core SPC - Changes with NO new additional data are submitted by the MAH | 19/01/2011 | n/a | PL | Changes to the PIL section 2. BEFORE YOU TAKE MYCLAUSEN - Take special care with Myclausen and Pregnancy and breast-feeding recommended by the CHMP following the assessment of the originator product. |
| IA/0002 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                         | 07/01/2011 | n/a |    |                                                                                                                                                                                                         |